Buy KEPPRA XR 750 MG Levetiracetam

KEPPRA XR 750 mg is an extended-release anticonvulsant tablet used to manage seizures in adults and children with epilepsy. This formulation provides steady medication levels over 24 hours for convenient once-daily dosing. Levetiracetam extended-release is designed for broad seizure control with a simplified schedule.

Strength

750mg

Pack Size

60s

Storage

Ambient

Manufacturer / TM Owner

UCB, Inc.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Levetiracetam extended-release 750 mg tablets are prescribed to reduce the frequency of partial-onset seizures in patients with epilepsy. It is also used as adjunctive therapy for generalized tonic-clonic seizures in adults and adolescents. This medication helps stabilize electrical activity in the brain to prevent seizure episodes.

Side Effects

Patients taking levetiracetam extended-release often report improved seizure control and fewer breakthrough episodes throughout the day. Some users experience mild drowsiness or dizziness, especially when starting treatment. These effects tend to lessen as the body adjusts to the medication.

Precautions & Warnings

Store levetiracetam extended-release at room temperature away from moisture and heat. Keep the medication in its original container with the desiccant to maintain potency. Always follow the prescribed schedule and do not crush or split the extended-release tablets unless directed by a healthcare provider.

Avoid Interactions

Levetiracetam may interact with central nervous system depressants such as alcohol or sedatives, which can increase drowsiness. Certain medications that affect liver enzymes, like some antiepileptics or rifampin, may alter levetiracetam levels. Always inform your healthcare provider about all prescription and over-the-counter medications you are taking.

References

Frequently Asked Questions

It is used to treat partial-onset seizures and generalized tonic-clonic seizures in patients with epilepsy.

Store at room temperature in the original container with the desiccant to protect from moisture.

Alcohol may increase drowsiness; consult your healthcare provider before consuming alcohol.

It is approved for use in adults and adolescents; pediatric dosing should be determined by a healthcare professional.

Take it as soon as you remember unless it is close to the next scheduled dose; do not double up.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.